Printer Friendly

Browse Biological products industry topic

Intellectual property subtopic

Articles

1-300 out of 494 article(s) nextnext page
Title Author Type Date Words
Spherix granted exclusive option to license G4-1 from University of Kentucky. Sep 11, 2019 244
PROPANC BIOPHARMA GRANTED US PATENT FOR PRP. Sep 1, 2019 331
Gilead Sciences Demands Review Into HIV Patents Given To US Government. Aug 22, 2019 130
BioInvent announces intention of USPTO to grant patent relating to BI-1206. Aug 16, 2019 179
BioInvent announces intention of USPTO to grant patent relating to BI-1206. Aug 16, 2019 175
Enzo Biochem, Inc. Announces Issuance of United States Patent for Advanced Nucleic Acid Hybridization Probe Technology for Clinical and Research Applications. Aug 6, 2019 785
Enzo Biochem issued patent for nucleic acid hybridization probe technology. Aug 5, 2019 103
Nexien BioPharma Granted a Patent by the Israeli Patent Office. Jul 19, 2019 230
Court rules in favour of DuPont in Novozymes' entitlement litigation. Jul 12, 2019 132
United States : Stabenow, Cummings Call for Government Accountability Office Review of Potential Patent Infringement by Gilead Pharmaceuticals. Jun 20, 2019 295
RedHill Biopharma receives allowance for U.S. patent covering RHB-104. Jun 10, 2019 207
U.S., Japan patent offices issue patent to AzurRx BioPharma for MTAN inhibitor. Jun 7, 2019 157
Enzo Biochem Issued United States Patent for Treatment of Liver Cancer Using Ozanimod. Disease/Disorder overview May 16, 2019 291
ARCA Biopharma files provisional patent application after GENETIC-AF findings. May 13, 2019 266
United States : Stabenow, Senators Raise Concerns about Potential Patent Infringement by Pharmaceutical Company Gilead Science and High Price of Its HIV-Prevention Drug, Truvada. Apr 25, 2019 293
BioInvent announces US patent protection for its F.I.R.S.T. platform. Mar 14, 2019 197
BioInvent announces US patent protection for its F.I.R.S.T. platform. Mar 14, 2019 198
Mizuho likes Biogen's odds in patent case against Mylan. Feb 7, 2019 127
MorphoSys announces asserted claims of three patents ruled invalid. Jan 28, 2019 155
US Patent Office Issues CEL-SCI Two Patents for Its LEAPS Vaccine Platform Technology. Jan 24, 2019 553
U.S. Patent Office issues CEL-SCI two patents for LEAPS technology. Jan 23, 2019 185
Navidea Biopharmaceuticals Wins Patent Extension for Lymphoseek. Dec 11, 2018 329
Navidea Biopharmaceuticals reports extension of Lymphoseek patent until 12 May 2025. Dec 10, 2018 157
Navidea Biopharmaceuticals reports extension of Lymphoseek patent until 12 May 2025. Dec 10, 2018 153
Vor Biopharma receives US patent for technology platform. Nov 30, 2018 295
Vor Biopharma receives US patent for technology platform. Nov 30, 2018 291
Vor Biopharma Issued Foundational US Patent Broadly Covering Compositions and Methods to Treat Hematologic Malignancies. Nov 30, 2018 658
Appeals court affirms Forward Pharma loss in patent fight with Biogen. Oct 24, 2018 131
Forward Pharma says appeals court affirms decision of PTAB on Biogen patent. Oct 24, 2018 162
Appeals court affirms Forward Pharma loss in patent fight with Biogen. Oct 24, 2018 132
BioInvent International announces receipt of notice of allowance from USPTO relevant to its F.I.R.S.T platform. Sep 27, 2018 178
BioInvent International announces receipt of notice of allowance from USPTO relevant to its F.I.R.S.T platform. Sep 27, 2018 179
RedHill Biopharma receives notice of allowance from USPTO for RHB-106. Aug 20, 2018 140
United States : CytRx Announces Centurion BioPharma Corporation's Filing of a Provisional Patent Application. Jul 28, 2018 428
Centurion BioPharma Files Provisional Patent Application for Companion Diagnostic for Albumin-binding Drug Candidates. Jul 27, 2018 227
European, Canadian Patents Issued for Thermostable Ricin Toxin Vaccine from Soligenix. Jul 13, 2018 223
BioInvent International announces intention by Japanese patent office to grant patent relevant to its F.I.R.S.T. platform. Jul 10, 2018 175
BioInvent International announces intention by Japanese patent office to grant patent relevant to its F.I.R.S.T. platform. Jul 10, 2018 171
Soligenix receives European, Canadian patents for Rivax formulation. Jul 9, 2018 178
RedHill Biopharma announces allowance of two RHB-104 patents. Jul 2, 2018 410
Patent Infringement: Defensive Strategies for IP Violators. Fitzpatrick, William M.; Dilullo, Samuel A. Jul 1, 2018 15555
Targovax ASA awarded European Patent for mutant-RAS specific neoantigen vaccine TG02. Jun 19, 2018 244
Targovax ASA awarded European Patent for mutant-RAS specific neoantigen vaccine TG02. Jun 19, 2018 240
LEAPS Vaccine Platform Technology Granted Two New Patents by USPTO. Jun 12, 2018 255
CEL-SCI announces two new U.S. patents for LEAPS platform technology. Jun 8, 2018 144
RedHill Biopharma announces U.S. patent for experimental Ebola therapy. May 29, 2018 284
Arbutus Biopharma, Roivant to launch joint venture for RNA-based therapeutics. Apr 11, 2018 272
Titan to Sell European Probuphine IP to Italy's Molteni. Mar 22, 2018 665
Titan to Sell European Probuphine IP to Italy's Molteni. Mar 22, 2018 668
Deal snapshot: TITAN TO SELL EUROPEAN PROBUPHINE IP TO ITALY'S MOLTENI. Mar 22, 2018 117
Strongbridge Biopharma get patent for methods of treating Cushing's syndrome. Mar 20, 2018 121
Australia : Bod's exclusive partner, iX Biopharma, secures China patent for drug delivery technology. Feb 26, 2018 589
RegeneRx awarded Canadian Patent for TI[superscript two]4 for treating neurological injury and damage. Feb 15, 2018 167
RegeneRx awarded Canadian Patent for TI[superscript two]4 for treating neurological injury and damage. Feb 15, 2018 163
United States : ViiV Healthcare alleges Gilead of patent infringement. Feb 13, 2018 177
GlaxoSmithKline, Pfizer venture files patent infringement litigation against Gilead. Feb 8, 2018 138
CEL-SCI Receives Patent for LEAPS Vaccine Platform Aimed at Influenza, Other Infectious Diseases. Feb 5, 2018 237
CEL-SCI says USPTO allows new patent for LEAPS vaccine platform technology. Jan 30, 2018 101
Ireland : Strongbridge Biopharma Receives Notice of Allowance from U.S. Patent and Trademark Office for New Patent Covering RECORLEV (levoketoconazole) for the Treatment of Cushings Syndrome. Jan 20, 2018 294
BioInvent to be granted European patent relevant to its F.I.R.S.T. platform. Jan 17, 2018 176
BioInvent to be granted European patent relevant to its F.I.R.S.T. platform. Jan 17, 2018 172
Regen BioPharma Files Additional Patent Application for NR2F6-Modulating Small Molecules. Dec 13, 2017 205
RedHill Biopharma granted Notice of Allowance from US Patent and Trademark Office for new patent. Oct 23, 2017 178
RedHill Biopharma granted Notice of Allowance from US Patent and Trademark Office for new patent. Oct 23, 2017 174
BioInvent to be granted patent by Japanese patent office for BI-1206. Sep 13, 2017 187
European Patent Office to Issue RegeneRx Patent for Peripheral Neuropathy Treatment. Aug 16, 2017 292
AzarGen Biotechnologies wins European patent for application: PRODUCTION OF RECOMBINANT HUMAN SURFACTANT PROTEIN-B. Jul 26, 2017 199
IP Developer Spherix Buys Into New Fibre Optic Patent Portfolio. Apr 20, 2017 144
IP Developer Spherix Buys Into New Fibre Optic Patent Portfolio. Apr 20, 2017 150
Deal snapshot: IP DEVELOPER SPHERIX BUYS INTO NEW FIBRE OPTIC PATENT PORTFOLIO. Apr 20, 2017 114
European Patent office upholds company's key patents. Apr 3, 2017 196
European Patent Office upholds company's key Patents. Apr 3, 2017 196
Celltrion challenges Genetech's Herpceptin patents. Mar 31, 2017 246
Celltrion challenges Genetech's Herpceptin patents. Mar 31, 2017 242
Gilead Sciences faces new legal challenge over patent of hepatitis C drug Sofosbuvir. Mar 28, 2017 261
Gilead Sciences faces new legal challenge over patent of hepatitis C drug Sofosbuvir. Mar 28, 2017 257
Biogen receives intellectual property ruling over Tecfidera. Mar 24, 2017 209
Biogen receives intellectual property ruling over Tecfidera. Mar 24, 2017 205
Palatin Technologies announces USPTO Notice of Allowance for Bremelanotide Methods for treating hypoactive sexual desire disorder. Mar 21, 2017 236
Palatin Technologies announces USPTO Notice of Allowance for Bremelanotide Methods for treating hypoactive sexual desire disorder. Mar 21, 2017 232
RegeneRx wins notice of acceptance of Australian patent for treatment of neural injury with Thymosin Beta 4. Jan 10, 2017 232
RegeneRx wins notice of acceptance of Australian patent for treatment of neural injury with Thymosin Beta 4. Jan 10, 2017 228
Conflicts, Splash Zones and a 'Wild Ride': A Look Back on the Quirkiest Patent Battles of 2016. Dec 30, 2016 1018
Conflicts, Splash Zones and a 'Wild Ride': A Look Back on the Quirkiest Patent Battles of 2016. Dec 30, 2016 1058
RegeneRx wins notice of intent to grant patent in EU for treating patients with neural injury. Dec 19, 2016 238
RegeneRx wins notice of intent to grant patent in EU for treating patients with neural injury. Dec 19, 2016 234
Jury Orders Gilead To Pay $2.54B In Royalties To Merck. Dec 16, 2016 338
Vitality Biopharma files international PCT patent application for development of cannabinoid pharmaceuticals platform. Nov 11, 2016 177
Vitality Biopharma files international PCT patent application for development of cannabinoid pharmaceuticals platform. Nov 11, 2016 173
RegeneRx awarded US patent notice of allowance for TI[superscript two]4 eye drop formulation. Nov 3, 2016 212
RegeneRx awarded US patent notice of allowance for TI[superscript two]4 eye drop formulation. Nov 3, 2016 208
BIOINVENT EXPANDS PATENT APPROVALS FOR BI-505. Oct 1, 2016 525
BioInvent granted additional patent approvals for BI-505. Sep 20, 2016 215
BioInvent granted additional patent approvals for BI-505. Sep 20, 2016 211
Palatin Technologies awarded US patent allowance for Melanocortin Receptor-Specific Heptapeptides. Jun 6, 2016 163
Palatin Technologies awarded US patent allowance for Melanocortin Receptor-Specific Heptapeptides. Jun 6, 2016 159
Palatin Technologies awarded US patent allowance for Melanocortin Peptide Intellectual Property, with potential application in inflammatory disease-related and autoimmune indications. May 27, 2016 197
Palatin Technologies awarded US patent allowance for Melanocortin Peptide Intellectual Property, with potential application in inflammatory disease-related and autoimmune indications. May 27, 2016 193
Companies sign cross-license agreement for pluripotent stem cell related patents. Feb 22, 2016 329
Companies sign cross-license agreement for pluripotents stem cell related patents. Feb 22, 2016 330
Can-Fite BioPharma receives US PTO's Notice of Allowance for A3 Adenosine Receptor Allosteric Modulators and its next-generation drug CF602. Jan 20, 2016 222
Can-Fite BioPharma receives US PTO's Notice of Allowance for A3 Adenosine Receptor Allosteric Modulators and its next-generation drug CF602. Jan 20, 2016 218
RedHill Biopharma receives Notice of Allowance from Israeli Patent Office covering the formulation of RHB-104. Sep 1, 2015 154
RedHill Biopharma receives Notice of Allowance from Israeli Patent Office covering the formulation of RHB-104. Sep 1, 2015 150
Court rules against StemCells in patent infringement suit. Jul 27, 2015 301
Court rules against StemCells in patent infringement case. Jul 27, 2015 318
RegeneRx Biopharmaceuticals receives Notice of Acceptance from Australian government for patent for (TB4). Jul 24, 2015 179
RegeneRx Biopharmaceuticals receives Notice of Acceptance from Australian government for patent for (TB4). Jul 24, 2015 175
Drugmakers' unwelcome surprise. Hemphill, Thomas A. Jun 22, 2015 1903
Regen BioPharma files US patent application. May 29, 2015 186
Regen BioPharma files US patent application. May 29, 2015 182
Aphios receives US Patent No. 9,034,347 for treatment of neurodegenerative diseases. May 22, 2015 190
Aphios receives US Patent No. 9,034,347 for treatment of neurodegenerative diseases. May 22, 2015 186
Biotech's 'disruptive innovations' to reshape Rx industry. Jan 5, 2015 659
ES Cell International, GE Healthcare cross-license cell assay patents. Dec 15, 2014 179
ES Cell International, GE Healthcare gross-license cell assay patents. Dec 15, 2014 179
Obviousness type double patenting and the Hatch-Waxman Act. Nov 21, 2014 743
Obviousness type double patenting and the Hatch-Waxman Act. Nov 21, 2014 780
Galena Biopharma reports patent notice of allowance for NeuVax to prevent recurrence of breast cancer tumor in Japan. Oct 14, 2014 231
Galena Biopharma reports patent notice of allowance for NeuVax to prevent recurrence of breast cancer tumor in Japan. Oct 14, 2014 227
Enzo Biochem wins novel vectors patent for gene therapy treatments in the US. Oct 8, 2014 169
Enzo Biochem wins novel vectors patent for gene therapy treatments in the US. Oct 8, 2014 165
Can-Fite BioPharma receives Japanese patent for liver regeneration clinical stage drug candidate CF102. Sep 8, 2014 207
Can-Fite BioPharma receives Japanese patent for liver regeneration clinical stage drug candidate CF102. Sep 8, 2014 203
Quarterly reports: biopharma boasts growth while patent losses continue to plague Big Pharma. Financial report Sep 1, 2014 1683
Gilead Sciences partners with the Medicines Patent Pool to expand access of TAF for HIV treatment in the developing world. Jul 24, 2014 181
Gilead Sciences partners with the Medicines Patent Pool to expand access of TAF for HIV treatment in the developing world. Jul 24, 2014 177
MorphoSys gains US, Chinese patents for Ylanthia antibody platform. Jul 18, 2014 235
BioTime announces patents in regenerative medicine. Jul 14, 2014 356
BioTime announces patents in regenerative medicine. Jul 14, 2014 356
Galena Biopharma receives notice of allowance of US Patent for NeuVax. Jul 3, 2014 206
Galena Biopharma receives notice of allowance of US Patent for NeuVax. Jul 3, 2014 202
BioInvent receives US patent for BI-505. Jun 26, 2014 117
BioInvent receives US patent for BI-505. Jun 26, 2014 113
Palatin Technologies awarded notice of patent protection for next generation of new peptides that target the melanocortin-4 receptor. Jun 11, 2014 191
Palatin Technologies awarded notice of patent protection for next generation of new peptides that target the melanocortin-4 receptor. Jun 11, 2014 187
Enzo Biochem announces issuance of patent for more efficient vector for use in gene therapy & and gene transfer technology. Jun 9, 2014 180
Companies settle patent dispute. Jun 2, 2014 235
Companies settle patent dispute. Jun 2, 2014 235
Laidlaw to lead Spherix preferred share offering. May 30, 2014 217
Laidlaw to lead Spherix preferred share offering. May 30, 2014 215
Hemispherx Biopharma receives US patent composition of matter covering Ampligen formulations. May 29, 2014 164
Hemispherx Biopharma receives US patent composition of matter covering Ampligen formulations. May 29, 2014 160
BioTime passes BSI ISO 13485 certification for HyStem hydrogels. May 29, 2014 192
BioTime passes BSI ISO 13485 certification for HyStem hydrogels. May 29, 2014 188
Can-Fite BioPharma receives European Patent for invention titled, 'Method for inducing hepatocyte proliferation and uses thereof'. May 9, 2014 163
Can-Fite BioPharma receives European Patent for invention titled, 'Method for inducing hepatocyte proliferation and uses thereof'. May 9, 2014 167
Cyclacel Pharmaceuticals receives two Japanese patents for sapacitabine. May 7, 2014 163
Cyclacel Pharmaceuticals receives two Japanese patents for sapacitabine. May 7, 2014 159
RegeneRx Biopharmaceuticals receives Notice of Allowance for second US patent for Thymosin beta 4. Apr 23, 2014 141
RegeneRx Biopharmaceuticals receives Notice of Allowance for second US patent for Thymosin beta 4. Apr 23, 2014 137
Cytomedix patent covers use of ALDH bright cells in stroke. Apr 7, 2014 324
BIONDVAX RECEIVES PATENT REGISTRATION APPROVAL. Apr 1, 2014 388
Galena Biopharma receives Notice of Acceptance for patent covering the use of NeuVax. Mar 4, 2014 151
Galena Biopharma receives Notice of Acceptance for patent covering the use of NeuVax. Mar 4, 2014 147
RegeneRx Biopharmaceuticals wins patent for Thymosin beta 4 for treating Dry Eye Syndrome in Israel. Feb 25, 2014 126
RegeneRx Biopharmaceuticals wins patent for Thymosin beta 4 for treating Dry Eye Syndrome in Israel. Feb 25, 2014 122
Medizone International Inc wins US patent for AsepticSure for the elimination of Anthrax in critical buildings, infrastructure and resources following biological attack. Jan 30, 2014 206
RegeneRx Biopharmaceuticals Inc awarded patent allowance in the US for neuro and muscular degenerative diseases. Jan 17, 2014 180
RegeneRx Biopharmaceuticals Inc awarded patent allowance in the US for neuro and muscular degenerative diseases. Jan 17, 2014 176
The new era of biologic regulation and patenting under the America Invents Act. Rucker, David I. Jan 1, 2014 12725
RegeneRx Biopharmaceuticals Inc secures Notice of Allowance for reversal of skin aging product in Canada. Dec 23, 2013 131
MorphoSys wins European patent for MOR208 cancer antibody. Dec 3, 2013 221
Palatin Technologies Inc awarded two natriuretic peptide receptor-specific mimetic patents in the US. Nov 13, 2013 183
Palatin Technologies Inc awarded two natriuretic peptide receptor-specific mimetic patents in the US. Nov 13, 2013 169
Cyclacel Pharmaceuticals receives two patents from US Patent and Trademark Office. Nov 7, 2013 149
Cyclacel Pharmaceuticals receives two patents from US Patent and Trademark Office. Nov 7, 2013 145
MorphoSys gets US patent for anticancer antibody MOR208. Oct 22, 2013 201
Medizonea[euro](tm)s AsepticSure hospital disinfection technology awarded US Patent. Oct 9, 2013 190
GeoVax receives notice of allowance for patent for HIV vaccine from US Patent and Trademark Office. Oct 9, 2013 132
GeoVax receives notice of allowance for patent for HIV vaccine from US Patent and Trademark Office. Oct 9, 2013 128
GeoVax Labs Inc awarded Notice of Patent Allowance in the US for DNA/MVA HIV vaccine technology. Oct 8, 2013 227
GeoVax Labs Inc awarded Notice of Patent Allowance in the US for DNA/MVA HIV vaccine technology. Oct 8, 2013 223
Galena Biopharma receives patent notification for pharmaceutical use of NeuVax. Aug 23, 2013 162
Galena Biopharma receives patent notification for pharmaceutical use of NeuVax. Aug 23, 2013 158
Regen BioPharma Inc licenses cancer gene silencing technology, expanding its cancer vaccine patent portfolio. Aug 9, 2013 213
Regen BioPharma Inc licenses cancer gene silencing technology, expanding its cancer vaccine patent portfolio. Aug 9, 2013 209
i"?Acorda Therapeutics receives US patent for ampyra. May 24, 2013 108
i"?Acorda Therapeutics receives US patent for ampyra. May 24, 2013 104
Amarin Corporation plc receives patent allowance notification of Vascepa and Statin therapy to reduce triglycerides. May 23, 2013 224
Amarin Corporation plc receives patent allowance notification of Vascepa and Statin therapy to reduce triglycerides. May 23, 2013 220
Acorda Therapeutics Inc receives additional US Patent for AMPYRA covering range of dosage strengths. May 21, 2013 193
Acorda Therapeutics Inc receives additional US Patent for AMPYRA covering range of dosage strengths. May 21, 2013 189
Palatin Technologies Inc receives patent allowance for melanocortin receptor-1 specific peptides. Mar 20, 2013 170
Palatin Technologies Inc receives patent allowance for melanocortin receptor-1 specific peptides. Mar 20, 2013 166
Biogen Idec wins US Patent Office's patent for TECFIDERA dosing regimen for MS. Mar 20, 2013 203
Biogen Idec wins US Patent Office's patent for TECFIDERA dosing regimen for MS. Mar 20, 2013 199
CRO strategic partnerships: benefits for small- and mid-sized biopharma. Schultz, Josh Mar 1, 2013 1890
Amarin Corporation plc gets patent allowance in the US for FDA approved Vascepa; with a wider range of EPA concentrations. Feb 8, 2013 223
RegeneRx Biopharmaceuticals Inc awarded Notice of Allowance for treatment of heart diseases in patients in China. Feb 8, 2013 116
Amarin Corporation plc gets patent allowance in the US for FDA approved Vascepa; with a wider range of EPA concentrations. Feb 8, 2013 219
RegeneRx Biopharmaceuticals Inc awarded Notice of Allowance for treatment of heart diseases in patients in China. Feb 8, 2013 112
Amarin Corporation plc to receive additional US patent allowance to protect the proposed Vascepa indication to lower triglycerides and LDL-C. Feb 4, 2013 274
BioTime to buy Geron's stem cell assets: private investor commits $10 million to help finance the deal. Jan 14, 2013 371
Amarin Corporation plc wins US Patent 8,324,195 for Vascepa for use in lipid science. Dec 5, 2012 173
Amarin Corporation plc wins US Patent 8,324,195 for Vascepa for use in lipid science. Dec 5, 2012 169
Amarin Corporation plc expects patent allowance for US Application 13/610,247 for Vascepa with exclusivity into 2030. Nov 27, 2012 209
Amarin Corporation plc expects patent allowance for US Application 13/610,247 for Vascepa with exclusivity into 2030. Nov 27, 2012 205
Amarin Corporation plc receives US Patent 8,314,086 to protect the commercial potential of Vascepa. Nov 21, 2012 165
Amarin Corporation plc receives US Patent 8,314,086 to protect the commercial potential of Vascepa. Nov 21, 2012 161
Can-Fite BioPharma to develop CF602 drug for the treatment of sexual dysfunction. Clinical report Nov 14, 2012 174
Can-Fite BioPharma to develop CF602 drug for the treatment of sexual dysfunction. Clinical report Nov 14, 2012 170
RegeneRx Biopharmaceuticals Inc wins Notice of Allowance in the US for new ophthalmic indications. Nov 6, 2012 157
RegeneRx Biopharmaceuticals Inc wins Notice of Allowance in the US for new ophthalmic indications. Nov 6, 2012 153
Amarin Corporation plc gets US Patent for Vascepa. Oct 31, 2012 167
Amarin Corporation plc gets US Patent for Vascepa. Oct 31, 2012 163
Amarin Corporation plc receives two US patents protection for Vascepa beyond 2030. Oct 24, 2012 154
Amarin Corporation plc receives two US patents protection for Vascepa beyond 2030. Oct 24, 2012 150
United Kingdom : GE Healthcare exercises option to Geron s cellular assay patents. Oct 9, 2012 344
RegeneRx Biopharmaceuticals Inc awarded key ophthalmic patent in Mexico with claims for dry eye syndrome & glaucoma. Sep 14, 2012 117
RegeneRx Biopharmaceuticals Inc awarded key ophthalmic patent in Mexico with claims for dry eye syndrome & glaucoma. Sep 14, 2012 113
United States : RegeneRx Receives Key Ophthalmic Patent in Mexico. Sep 14, 2012 137
Amarin Corporation plc gets patent allowance for US Application 13/284,408 for FDA approved Vascepa indication. Sep 7, 2012 149
Amarin Corporation plc gets patent allowance for US Application 13/284,408 for FDA approved Vascepa indication. Sep 7, 2012 145
Galena Biopharma Inc wins Folate Binding Protein cancer vaccine patent in Japan. Aug 14, 2012 182
Galena Biopharma Inc wins Folate Binding Protein cancer vaccine patent in Japan. Aug 14, 2012 178
StemCells, Inc. awarded Japanese patents for neural stem cells. Aug 13, 2012 284
StemCells, Inc. awarded Japanese patents for neural stem cells. Aug 13, 2012 285
Galena Biopharma awarded NeuVax patent by USPTO. Jul 18, 2012 157
RegeneRx Biopharmaceuticals Inc gets EU notice of key heart patent with Thymosin beta 4. Jul 10, 2012 161
Genentech announces new data from CLEOPATRA study showing Perjeta treatment significantly extends life of HER2-positive metastatic breast cancer patents. Jun 22, 2012 353
RegeneRx Biopharmaceuticals Inc awarded patents and allowances in Mexico and Israel. Apr 10, 2012 156
Israel,Mexico,United States : RegeneRx Receives Four New Patents and Allowances in Mexico and Israel. Apr 10, 2012 322
Codexis Inc wins patent in the US for enzymatic cellulosic biofuels programme. Mar 28, 2012 164
Helix Biomedix strengthens IP with 4 patents. Mar 1, 2012 161
MorphoSys granted new patent under MOR202 programme. Jan 23, 2012 194
Pharming announces US patent grant on C1 inhibitor use in ischemia reperfusion injury indications. Dec 12, 2011 205
-US court decision on Genmab infringing Genentech, Biogen Idec patent appealed. Dec 6, 2011 174
-US court decision on Genmab infringing Genentech, Biogen Idec patent appealed. Dec 6, 2011 165
BioMarin Pharmaceutical Inc reacquires USD81m intellectual property from Adelaide Health Authority. Dec 1, 2011 138
RegeneRx Biopharmaceuticals Inc gets US notice of allowance for skin protection and repair claims. Nov 30, 2011 156
Medizonea[euro](tm)s AsepticSure disinfection technology awarded Canadian patent. Nov 30, 2011 186
Pronova BioPharma wins patent lawsuit in Germany. Nov 23, 2011 123
-Court rules in favour of Pronova Biopharma, Pfizer Italia in patent lawsuit. Nov 23, 2011 140
-Court rules in favour of Pronova Biopharma, Pfizer Italia in patent lawsuit. Nov 23, 2011 142
RegeneRx Biopharmaceuticals Inc awarded Notice of Allowance for two cardiac-related patent applications in Australia and Mexico. Nov 18, 2011 153
RegeneRx gets notice of allowance for 2 cardiac-related patent applications. Nov 18, 2011 195
-US court rules in favour of Genmab, GSK in Arzerra patent dispute. Nov 17, 2011 160
-US court rules in favour of Genmab, GSK in Arzerra patent dispute. Nov 17, 2011 161
Genmab, GlaxoSmithKline win US patent dispute for Arzerra. Nov 17, 2011 143
Angel Biotechnology eases concerns over ECJ ruling on stem-cell patents. Oct 26, 2011 168
Profectus in-licenses patent portfolio to boost vaccine programme. Sep 22, 2011 233
US court rules against Acorda's litigation for patent infringement. Sep 8, 2011 161
Cellcura, IDT Biologika strike vaccine testing agreement. Sep 5, 2011 166
-Norwegian Cellcura, IDT Biologika seal vaccine testing contract. Sep 5, 2011 178
-Norwegian Cellcura, IDT Biologika seal vaccine testing contract. Sep 5, 2011 180
CEL-SCI awarded key patent for investigational cancer therapy Multikine in China. Aug 18, 2011 170
Acorda Therapeutics Inc reports allowance of second US patent application for multiple sclerosis drug AMPYRA. Aug 11, 2011 188
BioTime awarded second U.S. Glycosan hydrogel patent. Aug 1, 2011 557
QLT Issued U.S. Patent for Treatment of Retinal Diseases. Jul 1, 2011 652
QLT Inc receives US patent for QLT091001 for inherited or age-related retinal diseases. Jun 1, 2011 192
BioTime awarded patent for Glycosan hydrogel. May 23, 2011 440
EU legal and regulatory update. Kamstra, Gerry May 1, 2011 3138
Protecting your products from being copied abroad. May 1, 2011 690
RegeneRx notified of Australian patent grant for TB4. Feb 11, 2011 153
USPTO grants MorphoSys patent covering MOR103 compound. Feb 7, 2011 229
Vitrolife receives patent for Swemed Sense in Europe. Jan 14, 2011 202
MorphoSys, Pfizer ink licence and technology transfer agreement for Slonomics platform. Dec 10, 2010 129
RegeneRx receives Australian patent for use of TB4 for prevention of dermal responses. Dec 2, 2010 142
MAP Pharmaceuticals names Thomas P. McCracken vice president, Intellectual Property. Oct 22, 2010 141
RECIPHARMCOBRA BIOLOGICS GRANTED PLASMID PATENT. Sep 29, 2010 781
India capable of producing lower-cost HPV vaccine. Jul 10, 2010 746
Novozymes says too early for compensation claim in Danisco patent case. May 13, 2010 240
Danisco CEO says too early to comment on patent trial filed by Novozymes. May 13, 2010 231
Repligen announces Notice of Allowance of US uridine patent. May 1, 2010 234
The 'Cabilly' patent saga continues. Ting, Richard Apr 1, 2010 579
Genentech, Biogen Idec sue GSK for patent infringement. Mar 26, 2010 169
MorphoSys announces patent grant on HuCAL technology in Japan. Mar 15, 2010 109
MorphoSys AG secures new Japanese patent for core antibody technology. Mar 15, 2010 135
Bar Harbor BioTechnology to license PCR and Real-Time PCR patents. Feb 16, 2010 129
Acorda Therapeutics gets FDA approval for AMPYRA. Jan 25, 2010 261
Academic fraud today: its social causes and institutional responses. Epstein, Richard A. Jan 1, 2010 9549
StemCells reinforces US patent position. Dec 16, 2009 294
Palatin Technologies gets US patent for heart failure drug candidate. Dec 1, 2009 139
Palatin Technologies receives United States Patent allowance for Heart Failure Drug Candidate. Jul 1, 2009 408
Pangu BioPharma, aTyr Pharma's subsidiary in Hong Kong, files three patent applications. May 1, 2009 604
CEL-SCI files patent application to support company's treatment for more virulent strain of H1N1 swine and other influenza viruses. May 1, 2009 715
Genencor International obtains United States patent. Apr 1, 2009 80
CeNeRx BioPharma Awarded New Patent for its Innovative Compounds That Selectively Target Peripheral Cannabinoid Receptors. Mar 1, 2009 571
Repligen Licenses Patent Rights for Treatment of Bipolar Disorder. Mar 1, 2009 594
Therapure Biopharma obtains United States patent. Mar 1, 2009 80
Vaccine patent portfolio licensed from UK Ministry of Defence. Feb 1, 2009 476
Alexion and PDL BioPharma Resolve Patent Dispute. Dec 1, 2008 526
Genencor obtains United States patent. Nov 1, 2008 106
UK: Court of Appeal explains the limited application of the Biogen principle to product claims and upholds broad product claim protection for a novel enantiomer. Oct 1, 2008 1414
Biogen Idec obtains United States patent. Sep 1, 2008 118
Genentech/Biogen Idec European Patent Revoked. Aug 1, 2008 319
Gilead Sciences obtains United States patent. Aug 1, 2008 82
ImmunoVaccine Broadens Its Enhanced Immune Response Patent Protection to Japan. Jul 1, 2008 341
Probiodrug obtains United States patent. Brief article May 1, 2008 88
Heska obtains United States patent. Apr 1, 2008 159
United States Patent and Trademark Office Confirms Validity of Osteotech's United States Patent 5,676,146. Mar 1, 2008 217
GTC Biotherapeutics obtains United States patent. Mar 1, 2008 98
HELIX REPORTS NET LOSS OF $7,674,000 FOR FISCAL 2007. Financial report Dec 1, 2007 1900
Novozymes obtains United States patent. Nov 1, 2007 82
Repligen settles with ImClone in Erbitux lawsuit. Aug 1, 2007 306
Isis obtains United States patent. Brief article Aug 1, 2007 131
CryoLife patents woundsealing hydrogel foam. Molinaro, Hope Aug 1, 2007 102
Ruling in favor of Neuralstem leads to stay of Stemcells lawsuit. Jun 1, 2007 368
Maniv Energy obtains United States patent. Brief article Apr 1, 2007 100

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters